Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
Sima Lev – Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot (sima.lev@weizmann.ac.il) Targeting of estrogen receptor is commonly used as afirst-line treatment for hormone-positive […]
